Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Washington University in St. Louis
Headquarters: St. Louis, MO, United States of America
Website: http://www.wustl.edu
Year Founded: 1853
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Nov 6, 2024
Distillery Therapeutics
Extracellular vesicle delivery of myelin-derived self-peptides for CNS autoimmune diseases
BioCentury | Nov 4, 2024
Distillery Therapeutics
T helper cells transiently expressing autoantigens for CNS injury
BioCentury | Oct 31, 2024
Discovery & Translation
Science Spotlight: Macrophage-fibroblast cross-talk in heart failure
BioCentury’s roundup of translational innovations also includes synthetic gene regulators, three longevity genes and more
BioCentury | Feb 21, 2024
Discovery & Translation
LDL receptor decoys: an emerging strategy for alphaviruses
Engineered proteins mimicking host low-density lipoprotein receptors could block cellular entry by a wide range of alphaviruses
BioCentury | Jan 16, 2024
Regulation
Jan. 16 Quick Takes: Casgevy gains quick label expansion in β-thalassemia
Plus: Deerfield adds Washington University in St. Louis to arsenal of academic center collaborations and updates from Allakos, GSK
BioCentury | Aug 17, 2023
Discovery & Translation
Improved transgene insertion; plus Synlogic’s autoimmune probiotic and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 8, 2023
Distillery Therapeutics
Chimeric receptor to clear apoptotic cells in inflammation
BioCentury | Feb 2, 2023
Emerging Company Profile
PrecisionLife: learning from genetic interactions by cutting noise
U.K. company untangling genomic interactions to find targets in complex diseases
Items per page:
1 - 10 of 166